EUpolicy

Market Access

Europe’s new HTA reality: The JCA, one year on

Here, we examine the early realities of JCA implementation, exploring whether the system is delivering greater alignment across European markets.

News

Novo Nordisk wins Netherlands GLP-1 compounding lawsuit

A Dutch compounding pharmacy has been ordered to stop distributing a compounded nasal spray version of Novo Nordisk's GLP-1 agonist semaglutide.

Market Access

Three separate injections - blue, red, and yellow - take off against black background

Why global pharmaceutical reforms are quietly redirecting ra...

Publication of the 2026 Pharma Package by the Council of the EU represents the most significant reform of EU pharmaceutical legislation in over 20 yrs

News

EU seeks advice on Sanofi's response to mismarketing claim

The EU is asking for feedback on measures proposed by Sanofi to address concerns about an allegedly misleading marketing campaign for a flu vaccine.

News

Sanofi faces EU investigation over flu shot marketing

The European Commission is investigating a marketing campaign run by Sanofi for a flu vaccine, to see if it disparaged its only rival in the market.

News

EFPIA report adds to pressures on EU drug pricing policy

Pharma trade body EFPIA says access to new medicines is worsening across Europe, as it makes the socioeconomic case for spending more on novel drugs.

Europe’s new HTA reality: The JCA, one year on

Novo Nordisk wins Netherlands GLP-1 compounding lawsuit

Why global pharmaceutical reforms are quietly redirecting ra...

EU seeks advice on Sanofi's response to mismarketing claim

Sanofi faces EU investigation over flu shot marketing

EFPIA report adds to pressures on EU drug pricing policy

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

EUpolicy

Editor's Picks